Paul Krzyzanowski
Paul is a computational biologist and writer living in Toronto. He's been a contributor to Signals for three years, writing articles for the general public about how biotechnology and biomedical research can be used to solve pressing medical problems. Alongside Paul's experience in computational biology, bioinformatics, and molecular genetics, he's interested in how academic research develops into real world, commercial technology, and what's needed for the Canadian biotech industry needs to grow. Paul is currently a Post-doctoral Fellow at the Ontario Institute of Cancer Research. Prior to joining the OICR, he worked at the Ottawa Hospital Research Institute and earned a Ph.D. from the University of Ottawa, specializing in computational biology. And finally, Paul earned an H.B.Sc. from the University of Toronto a long time ago. Paul's blog can be read at www.checkmatescientist.net
Posts by: Paul
Human brains, frozen for 11 years, still yield pluripotent stem cells
> If your morning cup of coffee wasn’t enough to wake you up today, researchers from the New York Stem Cell Foundation and Columbia University just reported being able to generate iPS cells from human brain tissue that’s been frozen for 11 years: Induced pluripotent stem cells (iPSCs) derived from patients with neurodegenerative disease generally […]
“Freedom to operate” strategy positions BioTime for rapid growth
> This is part three of an interview series with Michael West, CEO of BioTime. Read parts one and two. The prospects for BioTime and other companies that operate in the tissue engineering and cell therapy market are good. The industry is growing by about 18% per year and is estimated to reach $11 billion […]
The many opportunities for products in the stem cell field: An interview with Michael West, part 2
This is part two of a series on Michael West. Read part one. When most people hear of new applications coming out of stem cell research it’s usually via headline grabbing soon-to-be-products like stem cell derived livers, replacement ears, transplantable retinas, among other potentially useful things. Any one of these applications has the chance of […]
The ever changing stem cell field: An interview with Michael West
. Earlier this summer I had the fortunate opportunity to speak with Dr. Michael West, of BioTime, and pick his brain on various aspects of the stem cell industry, what it’s faced, and where it might go. It was a perfect follow up to my post in March that explored BioTime’s acquisition of Geron’s stem […]
Stem cell detective work: How George Daley uncovers iPS cells’ secrets
George Daley (File photo) Immediately after last month’s ISSCR meeting, George Daley travelled to the University of Toronto where he had been invited to be an external reviewer on a PhD thesis defense. While there, Daley spoke to a packed audience interested in what he had to say about cell differentiation. In Boston just days […]
Comments